Quiescent lung cancer cells release exosomes that are internalized by BMSCs, enhancing the glycolytic capacity of BMSCs via the insulin-like growth factor 1 receptor (IGF-1R) signaling pathway. This evidence concerns the gene IGF1R and lung carcinoma.